Solid Phase Peptide Synthesis Market Analysis

The market is segmented on the basis of product into reagents, equipment, and others, out of which, the equipment segment is anticipated to grab the largest share by the end of 2022, on account of higher adoption rates of these instruments for the solid phase peptide synthesis. Moreover, the use of these instruments also leads to ease of operation, which is also projected to contribute to the growth of the segment during the forecast period.

On the basis of end-user, the pharmaceutical & biotechnology industry segment in the global solid phase peptide synthesis market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the growth in use of peptides for therapeutic development and increased research & development activities in this segment relating to genomics, molecular biology, and associated fields.

Our in-depth analysis of the global market includes the following segments:

Product	Reagents Equipment Others
End-User	Pharmaceutical & Biotechnology Industry Contract Development & Manufacturing Organizations Academic & Research Institutes Others

Frequently Asked Questions (FAQ)

Solid Phase Peptide Synthesis Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036.

The extensive research and development and the increasing technological advancements in development of solid phase peptide synthesizers will fuel the market growth.

Asia Pacific is predicted to hold largest revenue share by 2036, owing to rising demand for novel antibody and protein-based drugs and the increasing expenditure on research activities in the region.

The major players in the market include AAPPTec, LLC, CEM Corporation, Bachem Holding, and CSBio, among others.

Solid Phase Peptide Synthesis Market Analysis